what is in the covid portfolio of top pharma companies? | nithya balasubramanian to et now
Published 3 years ago • 1.8K plays • Length 6:49Download video MP4
Download video MP3
Similar videos
-
11:32
what does 2022 hold for pharma companies? | a vaidheesh & nithya balasubramanian
-
5:07
here's what is known about the coronavirus so far
-
4:37
pills to treat covid-19! all you need to know about pfizer's paxlovid and merck's molnupiravir
-
9:11
covid segment to be as big a part of revenue as non-covid segment for laboratories: a velumani
-
23:11
why we need to know covid-19’s origins: who chief scientist | in conversation | soumya swaminathan
-
3:28
coronavirus: under the microscope | abc news
-
10:04
the pandemic has accelerated the demand for organic food: n balasubramanian, ceo, sresta (24 mantra)
-
4:37
how will covid-19 and consumer sentiment impact fmcg stocks in fy22? | ideas for profit
-
1:02
inova's 2022 community report
-
5:03
what the second covid-19 ‘wave’ means for domestic pharma companies? | ideas for profit
-
14:27
covid-19 impact on the mental health of families | patricia lester & david feinberg | google health
-
0:43
post-covid tech: revolutionizing healthcare validation
-
9:41
the three ‘r’s in medicine use | nithushi samaranayake | tedxusrijayewardenepura
-
14:01
everything you need to know about investing during covid-19
-
14:06
innovation in global health amid the covid-19 pandemic
-
12:54
everything you need to know about buying a health insurance policy | the money show
-
12:17
'pranayama' - a solution for covid? | the money show
-
3:03
now, new pills to treat covid-19
-
1:02:18
medtech: the new norm of global healthcare in a post-covid era
-
25:25
ilsi am2020: contributions to health from processed foods now and in the future (susana socolovsky)
-
18:49
how to select an nfo amid the covid-19 crisis? | the money show
-
1:02:07
coronavirus and the future of infectious disease